FOXO4-DRI is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
FOXO4-DRI is being researched for skin applications. Competes with endogenous FOXO4 for p53 binding, disrupting their interaction and causing p53 to translocate to mitochondria. This triggers intrinsic apoptotic cell death specifically in senescent (age. Common dosages for this use range from 5-10 mg per dose 3 consecutive days per cycle.
Can FOXO4-DRI Help With Skin?
FOXO4-DRI (FOXO4 D-Retro-Inverso peptide) is being researched for skin applications based on its mechanism as a Senolytic peptide.
Competes with endogenous FOXO4 for p53 binding, disrupting their interaction and causing p53 to translocate to mitochondria. This triggers intrinsic apoptotic cell death specifically in senescent (aged, dysfunctional) cells while sparing healthy cells. The D-retro-inverso modification provides protease resistance and enhanced cellular penetration.
What Does the Research Show for FOXO4-DRI and Skin?
Demonstrated selective senolytic activity in chondrocytes and Leydig cells in peer-reviewed studies. Multiple in vitro and animal model studies confirm selectivity for senescent cells over healthy cells. No completed human trials.
The relevance to skin specifically comes from FOXO4-DRI's effects on senescent cell elimination, improved tissue function, cartilage regeneration, testosterone restoration, anti-aging.
What Protocol Is Used for Skin?
For skin applications, the standard FOXO4-DRI protocol is 5-10 mg per dose administered 3 consecutive days per cycle via subcutaneous or intravenous injection for 3-day dosing periods, repeated every 4-6 weeks for 16 weeks total.
Some researchers adjust dosing based on the specific skin application — see our FOXO4-DRI dosage guide for full protocol details.
Can Stacking Improve Skin Results?
Pairs with Epithalon (telomere maintenance) for comprehensive anti-aging — FOXO4-DRI removes damaged senescent cells while Epithalon maintains telomere length in healthy cells.
What Side Effects Apply to Skin Use?
Minimal side effects in preclinical studies. Potential transient inflammation during senescent cell clearance as cellular debris triggers immune response. No human safety data published.
Side effects are generally consistent regardless of the specific application. See our FOXO4-DRI side effects guide for details.
Calculate Your FOXO4-DRI Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for FOXO4-DRI.
Open Calculator →Bottom Line: FOXO4-DRI for Skin
FOXO4-DRI shows preliminary research potential for skin. Standard protocols (5-10 mg per dose, 3 consecutive days per cycle, 3-day dosing periods, repeated every 4-6 weeks for 16 weeks total) apply.
Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.
Complete Guide
FOXO4-DRI : Benefits, Dosage, Side Effects & Research
Related Reading
- FOXO4-DRI Dosage Guide
- FOXO4-DRI Benefits
- FOXO4-DRI Side Effects
- FOXO4-DRI Stacking Guide
- FOXO4-DRI Cycle Guide
- FOXO4-DRI Research
Research-Grade Sourcing
If you're going to research FOXO4-DRI, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is FOXO4-DRI?
FOXO4-DRI (FOXO4 D-Retro-Inverso peptide) is a Senolytic peptide. Synthetic peptide designed to disrupt FOXO4-p53 protein-protein interaction in senescent cells, with D-retro-inverso modification for protease resistance. It is researched for senescent cell elimination, improved tissue function, cartilage regeneration, testosterone restoration, anti-aging.
What is the recommended FOXO4-DRI dosage?
Common dosages: 5-10 mg per dose administered 3 consecutive days per cycle via subcutaneous or intravenous injection. Cycle length: 3-day dosing periods, repeated every 4-6 weeks for 16 weeks total. Half-life: prolonged by D-retro-inverso modification; specific human half-life not published. Use our peptide calculator for exact reconstitution math.
What are the side effects of FOXO4-DRI?
Minimal side effects in preclinical studies. Potential transient inflammation during senescent cell clearance as cellular debris triggers immune response. No human safety data published.
Is FOXO4-DRI safe?
FOXO4-DRI has shown a preliminary safety profile in research. Not FDA-approved. Research use only. All research should follow appropriate safety protocols.